-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BXuLrt3z5bGUFmO4v3/mchFS2RVaeM820MyGRnBewpabVcUaXw0c4yt+M0qczFu4 v6J8swa/6cY14JJ6b+5x6w== 0000895345-06-000871.txt : 20061109 0000895345-06-000871.hdr.sgml : 20061109 20061109140046 ACCESSION NUMBER: 0000895345-06-000871 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20061109 DATE AS OF CHANGE: 20061109 GROUP MEMBERS: JOHN LONDON GROUP MEMBERS: STEVEN M. WEINSTEIN GROUP MEMBERS: SUTTONBROOK CAPITAL PORTFOLIO L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AnorMED Inc. CENTRAL INDEX KEY: 0001341988 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980171581 STATE OF INCORPORATION: XX FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81132 FILM NUMBER: 061201055 BUSINESS ADDRESS: STREET 1: 200-20353 64TH AVENUE CITY: LANGLEY STATE: A1 ZIP: V2Y 1N5 BUSINESS PHONE: 604-530-1057 MAIL ADDRESS: STREET 1: 200-20353 64TH AVENUE CITY: LANGLEY STATE: A1 ZIP: V2Y 1N5 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SUTTONBROOK CAPITAL MANAGEMENT LP CENTRAL INDEX KEY: 0001176552 IRS NUMBER: 460465072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 654 MADISON AVE STREET 2: STE 1009 CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 2123084310 FORMER COMPANY: FORMER CONFORMED NAME: SUTTONBROOK CAPITAL MANAGEMENT LLC DATE OF NAME CHANGE: 20020628 SC 13D/A 1 ss13da_anormed.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1)* AnorMED Inc. - ------------------------------------------------------------------------------ (Name of Issuer) Common Shares Without Par Value - ------------------------------------------------------------------------------ (Title of Class of Securities) 035910108 - ------------------------------------------------------------------------------ (CUSIP Number) Brett Spector SuttonBrook Capital Management LP 598 Madison Avenue 6th Floor New York, NY 10022 (212) 588-6622 - ------------------------------------------------------------------------------ (Name, Address and Telephone Number of Persons Authorized to Receive Notices and Communications) November 7, 2006 - ------------------------------------------------------------------------------ (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box |_|. *The remainder of this cover page will be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but will be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13D - -------------------------- ----------------------- CUSIP No. 035910108 Page 2 of 8 - -------------------------- ----------------------- - ------------------------------------------------------------------------------ 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON SUTTONBROOK CAPITAL MANAGEMENT LP - ------------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| - ------------------------------------------------------------------------------ 3 SEC USE ONLY - ------------------------------------------------------------------------------ 4 SOURCE OF FUNDS AF - ------------------------------------------------------------------------------ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - ------------------------------------------------------------------------------ 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE - ------------------------------------------------------------------------------ 7 SOLE VOTING POWER NUMBER OF 0 SHARES ------------------------------------------------------------- BENEFICIALLY 8 SHARED VOTING POWER OWNED BY 0 ------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER EACH 0 REPORTING ------------------------------------------------------------- PERSON 10 SHARED DISPOSITIVE POWER WITH 0 - ------------------------------------------------------------------------------ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - ------------------------------------------------------------------------------ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |_| - ------------------------------------------------------------------------------ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0% - ------------------------------------------------------------------------------ 14 TYPE OF REPORTING PERSON PN - ------------------------------------------------------------------------------ SCHEDULE 13D - -------------------------- ----------------------- CUSIP No. 035910108 Page 3 of 8 - -------------------------- ----------------------- - ------------------------------------------------------------------------------ 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON SUTTONBROOK CAPITAL PORTFOLIO L.P. - ------------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| - ------------------------------------------------------------------------------ 3 SEC USE ONLY - ------------------------------------------------------------------------------ 4 SOURCE OF FUNDS WC, OO - ------------------------------------------------------------------------------ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - ------------------------------------------------------------------------------ 6 CITIZENSHIP OR PLACE OF ORGANIZATION CAYMAN ISLANDS - ------------------------------------------------------------------------------ 7 SOLE VOTING POWER NUMBER OF 0 SHARES ------------------------------------------------------------- BENEFICIALLY 8 SHARED VOTING POWER OWNED BY 0 ------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER EACH 0 REPORTING ------------------------------------------------------------- PERSON 10 SHARED DISPOSITIVE POWER WITH 0 - ------------------------------------------------------------------------------ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - ------------------------------------------------------------------------------ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |_| - ------------------------------------------------------------------------------ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0% - ------------------------------------------------------------------------------ 14 TYPE OF REPORTING PERSON PN - ------------------------------------------------------------------------------ SCHEDULE 13D - -------------------------- ----------------------- CUSIP No. 035910108 Page 4 of 8 - -------------------------- ----------------------- - ------------------------------------------------------------------------------ 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON JOHN LONDON - ------------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| - ------------------------------------------------------------------------------ 3 SEC USE ONLY - ------------------------------------------------------------------------------ 4 SOURCE OF FUNDS AF - ------------------------------------------------------------------------------ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - ------------------------------------------------------------------------------ 6 CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES - ------------------------------------------------------------------------------ 7 SOLE VOTING POWER NUMBER OF 0 SHARES ------------------------------------------------------------- BENEFICIALLY 8 SHARED VOTING POWER OWNED BY 0 ------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER EACH 0 REPORTING ------------------------------------------------------------- PERSON 10 SHARED DISPOSITIVE POWER WITH 0 - ------------------------------------------------------------------------------ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - ------------------------------------------------------------------------------ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |_| - ------------------------------------------------------------------------------ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0% - ------------------------------------------------------------------------------ 14 TYPE OF REPORTING PERSON IN - ------------------------------------------------------------------------------ SCHEDULE 13D - -------------------------- ----------------------- CUSIP No. 035910108 Page 5 of 8 - -------------------------- ----------------------- - ------------------------------------------------------------------------------ 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON STEVEN M. WEINSTEIN - ------------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| - ------------------------------------------------------------------------------ 3 SEC USE ONLY - ------------------------------------------------------------------------------ 4 SOURCE OF FUNDS AF - ------------------------------------------------------------------------------ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - ------------------------------------------------------------------------------ 6 CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES - ------------------------------------------------------------------------------ 7 SOLE VOTING POWER NUMBER OF 0 SHARES ------------------------------------------------------------- BENEFICIALLY 8 SHARED VOTING POWER OWNED BY 0 ------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER EACH 0 REPORTING ------------------------------------------------------------- PERSON 10 SHARED DISPOSITIVE POWER WITH 0 - ------------------------------------------------------------------------------ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - ------------------------------------------------------------------------------ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |_| - ------------------------------------------------------------------------------ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0% - ------------------------------------------------------------------------------ 14 TYPE OF REPORTING PERSON IN - ------------------------------------------------------------------------------ This Amendment No. 1 to Schedule 13D amends certain information contained in the Schedule 13D dated September 27, 2006 and filed on September 27, 2006 (the "Schedule 13D") by SuttonBrook Capital Management LP (the "Investment Manager"), SuttonBrook Capital Portfolio L.P. (the "Master Fund"), John London ("Mr. London") and Steven M. Weinstein ("Mr. Weinstein" and, together with the Investment Manager, the Master Fund and Mr. London, the "Filing Persons") relating to the common shares without par value (the "Common Stock"), of AnorMED Inc., a Canadian corporation (the "Company"). Capitalized terms used but not defined herein have the meanings ascribed to them in the Schedule 13D. ITEM 5. INTERESTS IN SECURITIES OF THE ISSUER. ------------------------------------- Item 5 is amended as follows: (a) As of November 7, 2006, the Filing Persons are no longer beneficial owners of any shares of Common Stock. (b) As of November 7, 2006, none of the Filing Persons have the power to vote or direct the vote with respect to, or to dispose or direct the disposition of, any shares of Common Stock. (c) On November 7, 2006, each of the Filing Persons tendered its shares of Common Stock into the tender offer by Dematal Corp, a Nova Scotia unlimited company and a wholly-owned subsidiary of Genzyme Corporation, a Massachusetts corporation at a price of $13.50 per share of Common Stock. Genzyme Corporation announced on November 7, 2006 that all shares of Common Stock tendered into the tender offer were accepted for payment. Upon such acceptance, the Filing Persons ceased to own, beneficially or otherwise, any shares of Common Stock. (d) Not applicable. (e) As of November 7, 2006, the Filing Persons are no longer beneficial owners of any shares of Common Stock. Accordingly, this amendment is the final amendment to Schedule 13D. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. November 9, 2006 SuttonBrook Capital Management LP By: SuttonBrook Holdings LLC, Its General Partner By: /s/ John London ------------------------------------ Name: John London Title: Managing Member SuttonBrook Capital Portfolio L.P. By: SuttonBrook Capital Partners LP, Its General Partner By: SuttonBrook Capital Associates LP, Its General Partner By: SuttonBrook Capital Associates LLC, Its General Partner By: /s/ John London -------------------------- Name: John London Title: Managing Member /s/ John London ---------------------------------- John London /s/ Steven M. Weinstein ---------------------------------- Steven M. Weinstein EXHIBIT 1 - JOINT FILING AGREEMENT Joint Filing Agreement The undersigned hereby agree that this Amendment No. 1 to Schedule 13D filed herewith relating to the common shares without par value of AnorMED Inc., is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, on behalf of each of the undersigned. This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument. November 9, 2006 SuttonBrook Capital Management LP By: SuttonBrook Holdings LLC, Its General Partner By: /s/ John London ------------------------------------ Name: John London Title: Managing Member SuttonBrook Capital Portfolio L.P. By: SuttonBrook Capital Partners LP, Its General Partner By: SuttonBrook Capital Associates LP, Its General Partner By: SuttonBrook Capital Associates LLC, Its General Partner By: /s/ John London -------------------------- Name: John London Title: Managing Member /s/ John London ---------------------------------- John London /s/ Steven M. Weinstein ---------------------------------- Steven M. Weinstein -----END PRIVACY-ENHANCED MESSAGE-----